Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens (Q69074850)
Jump to navigation
Jump to search
scientific article published on 01 July 1989
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens |
scientific article published on 01 July 1989 |
Statements
Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens (English)
Weil-Hillman G
Fisch P
Prieve AF
Sosman JA
Hank JA